|
| Researchers identified a significant pathology-associated increase in hepatic conventional dendritic cells (cDC) and further defined their source as non-alcoholic fatty liver disease-induced boost in cycling of cDC progenitors in the bone marrow. [Nature Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists uncovered and characterized a distinct population of inflammatory hepatic CXCR3+Th17 cells sufficient to exacerbate non-alcoholic fatty liver disease pathogenesis. [Cell Metabolism] |
|
|
|
| The authors investigated the roles of ROS in sorafenib resistance, and found suppressed ROS levels and reductive redox states in sorafenib-resistant hepatocellular carcinoma cells. [Signal Transduction and Targeted Therapy] |
|
|
|
| Investigators evaluated the hypothesis that myofibroblastic (activated) hepatic stellate cells and liver fibrosis could be safely reduced by inhibiting the cysteine/glutamate antiporter xCT. [Liver International] |
|
|
|
| Researchers found up regulated expression of SRSF1 and steroid receptor RNA activator 1 (SRA1)-L in highly metastatic HCCLM3, as well as in hepatocellular carcinomas with SRSF1 demonstrating the strongest correlation with SRA1-L. [Cell Death Discovery] |
|
|
|
| Scientists tested the protective properties of dimethyl fumarate (DMF) before or after paracetamol exposure. Following DMF administration, Nrf2 nuclear translocation was tracked at the single-cell level and target gene transactivation confirmed. [iScience] |
|
|
|
| Using hepatocellular carcinoma cells as model, researchers found that MALAT1-associated small cytoplasmic RNA and its parent lncRNA MALAT1 could both promote cell proliferation, migration, and invasion in vitro. [Cell Death Discovery] |
|
|
|
| Molecular docking revealed the binding of JS-K to TAGLN and silenced Transgelin (shTAGLN)-2.15 cells were resistant to JS-K cytotoxicity, suggesting that TAGLN could be an important target in JS-K anti-HBV-positive liver cancer cells. [Scientific Reports] |
|
|
|
| In vitro experiments confirmed that pretreatment of different human hepatocellular carcinoma cell lines with metformin reduced the effects of sorafenib on cell viability, proliferation and signaling. [Molecular Pharmacology] |
|
|
|
| Researchers identified an endocrine pathway regulated by uncoupling protein 1 (UCP1) that antagonized liver inflammation and pathology, independent of effects on obesity. [Nature Metabolism] |
| |
|
|
|
| The authors review current knowledge on the immunobiology and pathogenesis of hepatitis B virus infection, focusing in particular on the role of CD8+ T cells and on several recent breakthroughs that challenge current dogmas. [Nature Reviews Immunology] |
|
|
|
| Diet composition and in particular simple carbohydrate intake may promote the development of non-alcoholic fatty liver disease, whereas non-digestible carbohydrates, by affecting gut microbiota, may favor the integrity of gut wall and reduce inflammation, opposing this process. [European Journal of Clinical Nutrition] |
|
|
|
|
| Albireo Pharma, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Bylvay for the treatment of PFIC. [Albireo Pharma, Inc. (Globenews Wire, Inc.)] |
|
|
|
|
| January 12 – 14, 2022 Shanghai, China |
|
|
|
|
|
| Deep Genomics, Inc. – Toronto, Ontario, Canada |
|
|
|
| University of Pittsburgh – Pittsburgh, Pennsylvania, United States |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
| The Griffin Institute – Harrow, United Kingdom |
|
|
|
| University of Wisconsin-Madison – Madison, Wisconsin, United States |
|
|
|
|